First Allied Advisory Services’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$2.7M Buy
19,958
+63
+0.3% +$8.55K 0.09% 228
2020
Q2
$2.72M Sell
19,895
-1,235
-6% -$157K 0.1% 214
2020
Q1
$2.28M Sell
21,130
-1,560
-7% -$180K 0.1% 216
2019
Q4
$2.73M Sell
22,690
-865
-4% -$96.5K 0.09% 248
2019
Q3
$2.34M Sell
23,555
-2,614
-10% -$274K 0.08% 265
2019
Q2
$2.85M Sell
26,169
-1,750
-6% -$186K 0.1% 233
2019
Q1
$3.12M Buy
27,919
+4,087
+17% +$448K 0.11% 218
2018
Q4
$2.28M Sell
23,832
-327
-1% -$34.7K 0.09% 244
2018
Q3
$2.94M Buy
24,159
+2,689
+13% +$317K 0.1% 226
2018
Q2
$2.36M Sell
21,470
-9,429
-31% -$1.01M 0.09% 258
2018
Q1
$3.3M Sell
30,899
-7,517
-20% -$833K 0.13% 188
2017
Q4
$4.1M Buy
38,416
+778
+2% +$83.2K 0.16% 154
2017
Q3
$4.19M Sell
37,638
-4,161
-10% -$445K 0.18% 143
2017
Q2
$4.33M Buy
41,799
+22,287
+114% +$2.2M 0.19% 132
2017
Q1
$1.92M Sell
19,512
-3,549
-15% -$340K 0.1% 228
2016
Q4
$2.04M Sell
23,061
-2,682
-10% -$244K 0.1% 219
2016
Q3
$2.48M Sell
25,743
-1,059
-4% -$101K 0.13% 183
2016
Q2
$2.31M Sell
26,802
-366
-1% -$32.8K 0.13% 180
2016
Q1
$2.38M Sell
27,168
-22,245
-45% -$1.99M 0.13% 174
2015
Q4
$5.55M Buy
49,413
+9,174
+23% +$996K 0.29% 85
2015
Q3
$4.07M Buy
40,239
+3,276
+9% +$393K 0.22% 115
2015
Q2
$4.54M Buy
36,963
+2,010
+6% +$241K 0.2% 133
2015
Q1
$3.99M Buy
34,953
+12,702
+57% +$1.4M 0.26% 92
2014
Q4
$2.25M Sell
22,251
-1,710
-7% -$166K 0.16% 155
2014
Q3
$2.18M Sell
23,961
-3,609
-13% -$317K 0.17% 138
2014
Q2
$2.37M Sell
27,570
-4,860
-15% -$383K 0.17% 157
2014
Q1
$2.56M Buy
32,430
+1,809
+6% +$151K 0.19% 140
2013
Q4
$2.32M Buy
30,621
+7,338
+32% +$521K 0.19% 153
2013
Q3
$1.62M Buy
23,283
+867
+4% +$56.8K 0.09% 221
2013
Q2
$1.29M Buy
+22,416
New +$1.3M 0.1% 221

Other funds holding IBB